Spots Global Cancer Trial Database for Non-interventional Study With Nab-Paclitaxel (Abraxane®)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Non-interventional Study With Nab-Paclitaxel (Abraxane®)

Official Title: Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer

Study ID: NCT01689610

Conditions

Metastatic Breast Cancer

Interventions

Study Description

Brief Summary: The purpose of this non-interventional study is to collect data on the efficacy and safety of Nab-Paclitaxel in the routine application.

Detailed Description: The main focus of this non-interventional study is set on answering the following questions: * Can the results observed in controlled clinical trials regarding efficacy and safety be reproduced in the routine clinical setting? * Are the side-effects of nab-paclitaxel therapy observed in this study comparable to the previously described safety-profile in terms of frequency and intensity? * What are the main reasons for modification or termination of the nab-paclitaxel therapy? * How does nab-paclitaxel therapy influence the patients' quality of life? * What are the criteria for selecting nab-paclitaxel as therapy for metastatic breast cancer?